Ambey Laboratories Ltd

Ambey Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ambey Laboratories Ltd

₹ 70.1 -1.06%
13 Dec - close price
Company website NSE - SME: AMBEY
About

Incorporated in 1985, Ambey Laboratories manufactures agrochemical products for crop protection.[1]

Key Points

Agro Chemical Products[1]
2,4-D Amine Salt (480 gm. Liter SL)
2,4-D Amine Salt (625 gm. Liter SL)
2,4-D Amine Salt (720 gm. Liter SL)
2,4-D Amine Salt (806 gm. Liter SL)
2,4-D Amine Salt (840 gm. Liter SL)
2,4-D Amine Salt (866 gm. Liter SL)
2,4-D Acid Tech (98% min)
2,4-D Ethyl Ester Tech (95% min)
2,4-D 2-Ethylhexyl Ester Tech (96% min)
2,4-D Sodium Salt (95% min)
Hexaconazole (5% min)

Website NSE - SM
  • Market Cap ₹ 175 Cr.
  • Current Price ₹ 70.1
  • High / Low ₹ 97.2 / 56.1
  • Stock P/E 35.5
  • Book Value ₹ 29.9
  • Dividend Yield 0.00 %
  • ROCE 17.3 %
  • ROE 31.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.6%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 35.3 to 56.6 days.
  • Working capital days have increased from 46.1 days to 89.5 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2024 Sep 2024
60 68
56 62
Operating Profit 4 6
OPM % 7% 9%
1 1
Interest 1 2
Depreciation 1 1
Profit before tax 3 4
Tax % 33% 18%
2 3
EPS in Rs 0.94 1.19
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
82 85 105 120 128
72 74 97 111 118
Operating Profit 10 10 8 9 10
OPM % 12% 12% 7% 8% 8%
1 1 3 1 2
Interest 4 3 2 2 3
Depreciation 3 3 3 3 3
Profit before tax 3 5 6 5 6
Tax % -235% 26% 5% -42%
10 4 5 8 5
EPS in Rs 211.28 20.11 29.52 4.13 2.13
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 14%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -8%
TTM: 51%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 34%
Last Year: 31%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 5 18 18 19 25
Reserves -13 1 1 13 50
33 18 14 30 14
20 19 21 18 46
Total Liabilities 45 56 54 79 135
16 25 25 24 24
CWIP 1 0 0 4 7
Investments 0 0 1 1 1
28 31 28 51 102
Total Assets 45 56 54 79 135

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
3 6 10 -13
-1 -1 -4 -5
-1 -5 -6 14
Net Cash Flow 0 -0 0 -4

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 31 37 12 57
Inventory Days 78 75
Days Payable 74 54
Cash Conversion Cycle 31 37 17 78
Working Capital Days 5 27 22 90
ROCE % 25% 22% 17%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2024
69.90%
1.46%
4.11%
24.53%
No. of Shareholders 1,520

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings